| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7649b77c98cdca3647fe825abf0b4402 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate |
2008-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c7cf091724736c1112967dbbbe89a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d559fa3683abea12f97dc212ea5ddd39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_621bc11f8b87866fc1394cbc07c3ed5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c920272512b2039427a2b32c3111c4af |
| publicationDate |
2008-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008300226-A1 |
| titleOfInvention |
Combination of Anticholinergics and Glucocorticoids for the Long-Term Treatment of Asthma and COPD |
| abstract |
The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548875-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8808713-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9006461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011135737-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8324266-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9415009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8558008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471468-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9463161-B2 |
| priorityDate |
2004-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |